Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NVS compared with TAK: revenue, margins and what each company keeps, and the suppliers and customers both name
NVS
Novartis AG
Change
Mkt cap
Revenue
Revenue
TAK
Takeda Pharmaceutical Co Ltd
Change
Mkt cap
Revenue
Revenue
vs
Compare
NVS
Novartis AG
vs
TAK
Takeda Pharmaceutical Co Ltd
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
NVS
1 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Oct 27 '26
±4.9%
▲
+1.98%
×0.41
TAK
1 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Oct 29 '26
±12.8%
▼
−0.69%
×0.05
= implied
NVS realized, solid
TAK realized, hatched
One scale, both sides: full bar = 13%
× = |realized| ÷ implied
Source: market data
NVS
Novartis AG
Change
161.99
▲
+0.04%
· post 162.00
Mkt cap
$310.2B
TAK
Takeda Pharmaceutical Co Ltd
Change
21.01
▼
−0.85%
· post 21.02
Closed
Nov 6 '26
Mkt cap
$36.2B
vs
Compare
Closed
Nov 6 '26
NVS
Novartis AG
vs
TAK
Takeda Pharmaceutical Co Ltd
161.99
▲
+0.04%
post 162.00
Price
21.01
▼
−0.85%
post 21.02
$310.2B
Mkt cap
$36.2B
Change
Change
NVS
161.99
▲
+0.04%
vs
TAK
21.01
▼
−0.85%
Closed
Nov 6 '26